Emerald Advisers’s Insmed INSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.63M | Buy |
15,252
+3,262
| +27% | +$395K | 0.04% | 137 |
|
|
2026
Q1 | $1.96M | Hold |
11,990
| – | – | 0.06% | 130 |
|
|
2025
Q4 | $2.09M | Sell |
11,990
-403
| -3% | -$73.5K | 0.06% | 123 |
|
|
2025
Q3 | $1.78M | Sell |
12,393
-871
| -7% | -$107K | 0.06% | 130 |
|
|
2025
Q2 | $1.33M | Sell |
13,264
-580,749
| -98% | -$44.4M | 0.05% | 129 |
|
|
2025
Q1 | $45.3M | Sell |
594,013
-90,623
| -13% | -$6.93M | 2.04% | 4 |
|
|
2024
Q4 | $47.3M | Sell |
684,636
-5,171
| -0.7% | -$372K | 1.83% | 6 |
|
|
2024
Q3 | $50.4M | Buy |
689,807
+49,540
| +8% | +$3.66M | 1.95% | 5 |
|
|
2024
Q2 | $42.9M | Buy |
640,267
+10,088
| +2% | +$391K | 1.8% | 7 |
|
|
2024
Q1 | $17.1M | Sell |
630,179
-300,670
| -32% | -$8.41M | 0.69% | 59 |
|
|
2023
Q4 | $28.8M | Sell |
930,849
-6,667
| -0.7% | -$173K | 1.23% | 19 |
|
|
2023
Q3 | $23.7M | Sell |
937,516
-51,510
| -5% | -$1.18M | 1.15% | 25 |
|
|
2023
Q2 | $20.9M | Sell |
989,026
-1,756
| -0.2% | -$33.3K | 0.91% | 49 |
|
|
2023
Q1 | $16.9M | Sell |
990,782
-4,131
| -0.4% | -$80.3K | 0.81% | 52 |
|
|
2022
Q4 | $19.9M | Buy |
+994,913
| New | +$19.2M | 0.96% | 42 |
|
|
2020
Q1 | – | Sell |
-674,167
| Closed | -$16.1M | – | 269 |
|
|
2019
Q4 | $16.1M | Sell |
674,167
-310,820
| -32% | -$6.32M | 0.68% | 56 |
|
|
2019
Q3 | $17.4M | Buy |
984,987
+69,468
| +8% | +$1.34M | 0.81% | 43 |
|
|
2019
Q2 | $23.4M | Sell |
915,519
-6,008
| -0.7% | -$167K | 0.94% | 36 |
|
|
2019
Q1 | $26.8M | Buy |
921,527
+318,482
| +53% | +$8.25M | 1.09% | 33 |
|
|
2018
Q4 | $7.91M | Sell |
603,045
-188,429
| -24% | -$3.01M | 0.39% | 89 |
|
|
2018
Q3 | $16M | Buy |
791,474
+72,585
| +10% | +$1.64M | 0.59% | 82 |
|
|
2018
Q2 | $17M | Sell |
718,889
-8,057
| -1% | -$207K | 0.64% | 73 |
|
|
2018
Q1 | $16.4M | Sell |
726,946
-132,065
| -15% | -$3.48M | 0.66% | 62 |
|
|
2017
Q4 | $26.8M | Sell |
859,011
-4,062
| -0.5% | -$120K | 1.03% | 29 |
|
|
2017
Q3 | $26.9M | Sell |
863,073
-422,292
| -33% | -$8.04M | 1.1% | 29 |
|
|
2017
Q2 | $22.1M | Buy |
1,285,365
+240,048
| +23% | +$4.1M | 0.92% | 49 |
|
|
2017
Q1 | $18.3M | Sell |
1,045,317
-295,003
| -22% | -$4.55M | 0.75% | 51 |
|
|
2016
Q4 | $17.7M | Buy |
1,340,320
+339,710
| +34% | +$4.63M | 0.76% | 52 |
|
|
2016
Q3 | $14.5M | Buy |
1,000,610
+370,451
| +59% | +$4.64M | 0.65% | 53 |
|
|
2016
Q2 | $6.21M | Buy |
630,159
+43,240
| +7% | +$505K | 0.3% | 112 |
|
|
2016
Q1 | $7.44M | Sell |
586,919
-23,512
| -4% | -$309K | 0.36% | 94 |
|
|
2015
Q4 | $11.1M | Buy |
610,431
+126,774
| +26% | +$2.23M | 0.52% | 70 |
|
|
2015
Q3 | $8.98M | Buy |
483,657
+60,698
| +14% | +$1.52M | 0.47% | 71 |
|
|
2015
Q2 | $10.3M | Buy |
422,959
+6,337
| +2% | +$144K | 0.49% | 70 |
|
|
2015
Q1 | $8.76M | Buy |
+416,622
| New | +$7.34M | 0.44% | 77 |
|
Other funds holding INSM
BBA
DGM
OAG
Emerald Advisers's INSM Position: Q2 2026 in Review
Emerald Advisers increased its Insmed (INSM) stake by 27% in Q2 2026, buying an estimated $395K and bringing the position to 15,252 shares worth $1.63M. The position accounts for 0.04% of the portfolio, ranked #137.
Emerald Advisers first reported a position in INSM in Q1 2015 and has held it in 35 quarters since. The position peaked at $50.4M in Q3 2024. 663 funds tracked by Wall St. Rank hold INSM as of Q2 2026.
- Emerald Advisers held 15,252 shares of Insmed worth $1.63M as of Q2 2026.
- Emerald Advisers bought 3,262 Insmed shares in Q2 2026, an estimated $395K.
- Insmed made up 0.04% of Emerald Advisers's portfolio in Q2 2026, its #137 holding.
- Emerald Advisers first reported a position in Insmed in Q1 2015 and has held it in 35 quarters since.
- Emerald Advisers's Insmed position peaked at $50.4M in Q3 2024.
- 663 funds tracked by Wall St. Rank held Insmed as of Q2 2026.
Based on Emerald Advisers's 13F filing for Q2 2026, filed 5 Aug 2026.